ENTRY       D10255                      Drug
NAME        Anagrelide hydrochloride hydrate (JAN);
            Anagrelide hydrochloride monohydrate;
            Agrylin (TN)
PRODUCT     AGRYLIN (Takeda Pharmaceuticals America)
  GENERIC   ANAGRELIDE (Torrent Pharmaceuticals Limited)
            ANAGRELIDE HYDROCHLORIDE (Teva Pharmaceuticals USA)
FORMULA     C10H7Cl2N3O. HCl. H2O
EXACT_MASS  308.9839
MOL_WEIGHT  310.5643
CLASS       Cardiovascular agent
             DG01507  Phosphodiesterase III inhibitor
            Metabolizing enzyme substrate
             DG01891  CYP1A1 substrate
             DG01892  CYP1A2 substrate
REMARK      Therapeutic category: 4299
            ATC code: L01XX35
            Chemical structure group: DG00727
            Product (DG00727): D10255<JP/US>
EFFICACY    Thrombocythemia treatment, Platelet aggregation inhibitor, Phosphodiesterase inhibitor
TARGET      PDE3 [HSA:5139 5140] [KO:K19021 K13296]
  PATHWAY   hsa00230(5139+5140)  Purine metabolism
METABOLISM  Enzyme: CYP1A1 [HSA:1543], CYP1A2 [HSA:1544]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX35 Anagrelide
                  D10255  Anagrelide hydrochloride hydrate (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Blood Products and Modifiers, Other
               Blood Products and Modifiers, Micellaneous
                Anagrelide
                 D10255  Anagrelide hydrochloride hydrate (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4299  Others
                 D10255  Anagrelide hydrochloride hydrate (JAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01507  Phosphodiesterase III inhibitor
               DG00727  Anagrelide
                D10255  Anagrelide hydrochloride hydrate
             Metabolizing enzyme substrate
              DG01891  CYP1A1 substrate
               DG00727  Anagrelide
                D10255  Anagrelide hydrochloride hydrate
              DG01892  CYP1A2 substrate
               DG00727  Anagrelide
                D10255  Anagrelide hydrochloride hydrate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Phosphodiesterases
                PDE3
                 D10255  Anagrelide hydrochloride hydrate (JAN) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10255
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10255
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01507  Phosphodiesterase III inhibitor
               DG00727  Anagrelide
             Metabolizing enzyme substrate
              DG01891  CYP1A1 substrate
               DG00727  Anagrelide
              DG01892  CYP1A2 substrate
               DG00727  Anagrelide
DBLINKS     CAS: 823178-43-4
            PubChem: 163312286
ATOM        18
            1   N1y N    20.7900  -16.7300
            2   C2y C    20.7900  -18.1300
            3   N2x N    19.6000  -18.8300
            4   C8y C    18.3400  -18.1300
            5   C8y C    18.3400  -16.7300
            6   C1x C    19.5300  -16.0300
            7   C8y C    17.1500  -16.0300
            8   C8y C    15.8900  -16.7300
            9   C8x C    15.8900  -18.1300
            10  C8x C    17.1500  -18.8300
            11  X   Cl   17.1500  -14.6300
            12  X   Cl   14.7000  -16.0300
            13  N1x N    22.1200  -18.5500
            14  C5x C    22.8900  -17.4300
            15  C1x C    22.1200  -16.3100
            16  O5x O    24.2900  -17.4300
            17  X   Cl   26.8800  -15.7500
            18  O0  O    27.3700  -18.8300
BOND        18
            1     2   3 2
            2     3   4 1
            3     4   5 2
            4     5   6 1
            5     6   1 1
            6     1   2 1
            7     5   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11   10   4 1
            12    7  11 1
            13    8  12 1
            14    2  13 1
            15   13  14 1
            16   14  15 1
            17    1  15 1
            18   14  16 2
///
